Business Wire

Promising Efficacy and Safety With Four-Week Extended Dosing Data Shows Dose-Dependent Reduction of LDH and Increased Hemoglobin Levels That Demonstrate Clinically Meaningful Hemolysis Inhibition CANbridge Plans to Advance to Pivotal Trial CANbridge to Hold Investor CallBEIJING & BURLINGTON, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals, Inc....

KYOTO, Japan--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has today announced the introduction of a new ultrasonic sensor device intended for deployment in automotive applications. With high-sensitivity and rapid responsiveness, the MA48CF15-7N is housed in a hermetically-sealed...

SHANGHAI--(BUSINESS WIRE)--From June 13th to 15th, ZPMC (Shanghai Zhenhua Heavy Industries Co.,Ltd) unveiled the 2023 European Container Supply Chain Exhibition (TOC Euro) at the Ahoy Center in Rotterdam, Netherlands. During the exhibition, ZPMC met with significant clients, including Maersk...

Revolutionary one-time pancreatic gene therapy resulted in up to 54% lower blood glucose and 20% lower total body weight than chronic semaglutide 10 nmol/kg/day in the db/db rodent model Proprietary Fractyl delivery technology combined with proprietary AAV-based gene therapy results...

The company will showcase its latest innovative solutions to enable rapid diagnosis, Theranostics, and precision care at #SNMMI23 Clinicians and patients are aligned in what they want: A healthcare experience that is more human and flexible, focusing on the needs...

- Data Presented During Oral Session at EASL 2023 Demonstrate Fazirsiran’s Promising Impact on Key Markers of Liver Disease - AATD-LD is a Rare Genetic Disease Affecting Children and Adults with no Approved Treatments - Takeda and Arrowhead are Advancing Fazirsiran...

-Study results demonstrated favorable safety, tolerability, and PK profile -Clinically significant weight loss was observed in only 28 days -Positive trends in lipids and glucose effects were also shown MONTREAL & SAN DIEGO--(BUSINESS WIRE)--#CB1--Inversago Pharma Inc. (“Inversago”), a leader in the development...

Entrepreneur Of The Year celebrates business leaders and entrepreneurs who are building a better world HARVEY, Ill.--(BUSINESS WIRE)--Atkore Inc. (NYSE: ATKR) today announced that William (Bill) Waltz, President and CEO of Atkore Inc., was named an Entrepreneur Of The Year®...

– All six patients treated with VX-880 engrafted islet cells, produced endogenous insulin (C-peptide) and had improved glycemic control while reducing or eliminating insulin use – – The two patients with at least one year of follow-up met the criteria...

LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12 NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved LITFULO™ (ritlecitinib), a once-daily...